吸入贝克罗梅他松二opionate/formoterol fumarate/glycopyrronium对腹膜工作量和肺功能在不受控制的喘的影响:一个病例报告
Antonio Maiorano1, Chiara Lupia1, Nicola Montenegro1
1Department of Health Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Frontiers in medicine
|March 20, 2024
概括
单个吸入器用贝克罗梅他松二 propionate/formoterol fumarate/glycopyrronium (BDP/FF/G) 的三重治疗改善了喘控制和减少了隔膜工作量. 隔膜超声波显示了这些改善,为无法控制的喘患者提供了一种新的监测方法.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 诊断成像 诊断成像 诊断成像
背景情况:
- 失控的喘需要有效的治疗策略.
- 贝克罗梅他松二 propionate/formoterol fumarate/glycopyrronium (BDP/FF/G) 是一种用于治疗喘的额外精细的三重疗法.
- 关于使用隔膜超声波来监测吸入性喘治疗的数据有限.
研究的目的:
- 为了研究BDP/FF/G三重治疗在成人喘患者的疗效.
- 评估隔膜超声波在监测治疗反应中的实用性.
- 为了评估肺功能变化,喘控制和腹膜工作量.
主要方法:
- 一个78岁女性患有失控喘的案例研究.
- 治疗开始时使用吸入式皮质类固醇/长效β2上腺激动剂 (ICS/LABA).
- 转向BDP/FF/G单片吸入器三重疗法. 一个吸入器的三重疗法.
- 使用喘控制问卷-5 (ACQ-5),肺功能测试和腹膜超声波进行评估.
主要成果:
- 患者在ACQ-5得分和肺功能测试中显示出改善.
- 隔膜超声波显示减少了加厚分数 (TF) 和正常化的措施.
- 这些变化表明,在三重治疗7天后,隔膜工作量减少.
结论:
- 这是关于肺功能和隔膜超声波参数同时改善的首份报告.
- 短期BDP/FF/G三重疗法有效降低了成人喘患者的腹膜工作量.
- 隔膜超声波可以作为监测喘治疗反应的宝贵工具.
相关概念视频
Inhaled Medications
256
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
256
Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
COPD: Management Using Bronchodilators and Corticosteroids
205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Antiasthma Drugs: Methylxanthines
228
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
228
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
245
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
245


